JP2003514565A5 - - Google Patents

Download PDF

Info

Publication number
JP2003514565A5
JP2003514565A5 JP2001539890A JP2001539890A JP2003514565A5 JP 2003514565 A5 JP2003514565 A5 JP 2003514565A5 JP 2001539890 A JP2001539890 A JP 2001539890A JP 2001539890 A JP2001539890 A JP 2001539890A JP 2003514565 A5 JP2003514565 A5 JP 2003514565A5
Authority
JP
Japan
Prior art keywords
cell
site
vector
vpx
vpr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001539890A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003514565A (ja
Filing date
Publication date
Priority claimed from EP99123498A external-priority patent/EP1103615A1/en
Application filed filed Critical
Publication of JP2003514565A publication Critical patent/JP2003514565A/ja
Publication of JP2003514565A5 publication Critical patent/JP2003514565A5/ja
Pending legal-status Critical Current

Links

JP2001539890A 1999-11-25 2000-11-24 非分裂細胞を不死化する能力をもつベクター及び前記ベクターで不死化された細胞 Pending JP2003514565A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99123498.0 1999-11-25
EP99123498A EP1103615A1 (en) 1999-11-25 1999-11-25 Vectors capable of immortalizing non-dividing cells and cells immortalized with said vectors
PCT/EP2000/011723 WO2001038548A2 (en) 1999-11-25 2000-11-24 Vectors capable of immortalizing non-dividing cells and cells immortalized with said vectors

Publications (2)

Publication Number Publication Date
JP2003514565A JP2003514565A (ja) 2003-04-22
JP2003514565A5 true JP2003514565A5 (enExample) 2008-01-24

Family

ID=8239461

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001539890A Pending JP2003514565A (ja) 1999-11-25 2000-11-24 非分裂細胞を不死化する能力をもつベクター及び前記ベクターで不死化された細胞

Country Status (6)

Country Link
US (1) US20090142841A1 (enExample)
EP (2) EP1103615A1 (enExample)
JP (1) JP2003514565A (enExample)
AU (1) AU2667901A (enExample)
CA (1) CA2389667A1 (enExample)
WO (1) WO2001038548A2 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8883507B2 (en) 2005-10-18 2014-11-11 The Regents Of The University Of Colorado Conditionally immortalized long-term hematopoietic stem cells and methods of making and using such cells
CA2680613A1 (en) 2007-03-13 2008-09-18 National Jewish Medical And Research Center Methods for generation of antibodies
TW200902708A (en) 2007-04-23 2009-01-16 Wyeth Corp Methods of protein production using anti-senescence compounds
SG10201803982TA (en) 2008-05-16 2018-07-30 Taiga Biotechnologies Inc Antibodies and processes for preparing the same
DK2313496T3 (en) * 2008-07-21 2014-12-15 Taiga Biotechnologies Inc Anukleære differentiated cells, and method for preparation thereof
US8784825B2 (en) 2008-08-28 2014-07-22 Taiga Biotechnologies, Inc. Modulators of MYC, methods of using the same, and methods of identifying agents that modulate MYC
EP2501801A1 (en) 2009-11-18 2012-09-26 The Board of Trustees of The Leland Stanford Junior University Methods of inducing tissue regeneration
JP5863338B2 (ja) * 2011-08-25 2016-02-16 株式会社東芝 プラスミド型ベクター、遺伝子プロモーター活性の検出方法、及びアッセイキット
ES2634457T3 (es) 2011-10-18 2017-09-27 Univercell Biosolutions Producción de una línea de células beta humanas a partir de un páncreas postnatal temprano
JP6285930B2 (ja) 2012-07-20 2018-02-28 タイガ バイオテクノロジーズ，インク． 造血コンパートメントの再構築及び自家再構築の増進
WO2014109696A1 (en) * 2013-01-10 2014-07-17 Alf Grandien Method for immortalization of b cells and uses thereof
US10272115B2 (en) 2013-03-11 2019-04-30 Taiga Biotechnologies, Inc. Production and use of red blood cells
US9365825B2 (en) 2013-03-11 2016-06-14 Taiga Biotechnologies, Inc. Expansion of adult stem cells in vitro
CN103468746B (zh) * 2013-09-28 2015-03-04 青岛麦迪赛斯生物科技有限公司 一种肿瘤细胞系的构建方法
CA3024296A1 (en) 2016-05-11 2017-11-16 Animal Cell Therapy - Act Production of a canine beta cell line from an immature pancreas
US10583156B2 (en) 2016-12-02 2020-03-10 Taiga Biotechnologies, Inc. Nanoparticle formulations
US10149898B2 (en) 2017-08-03 2018-12-11 Taiga Biotechnologies, Inc. Methods and compositions for the treatment of melanoma
EP3707243A1 (en) 2017-11-08 2020-09-16 Animal Cell Therapy - Act Production of canine pancreatic islets from an immature pancreas
EP3952909A4 (en) 2019-04-08 2023-06-07 Taiga Biotechnologies, Inc. COMPOSITIONS AND METHODS FOR CRYOPRESERVING IMMUNE CELLS
SG11202112529WA (en) 2019-05-14 2021-12-30 Taiga Biotechnologies Inc Compositions and methods for treating t cell exhaustion
CN111154807B (zh) * 2020-01-17 2023-03-24 山东农业大学 一种分泌型的崂山奶山羊乳腺上皮细胞系的构建方法
WO2022066937A1 (en) * 2020-09-23 2022-03-31 Regents Of The University Of Minnesota Immortalized keratinocytes, lentivirus for keratinocyte immortalization, and methods of use
US20230407268A1 (en) * 2020-11-06 2023-12-21 Trans Chromosomics, Inc. Method for producing reversibly immortalized cell
KR102572595B1 (ko) * 2020-12-02 2023-08-31 충북대학교 산학협력단 불멸화 고양이줄기세포 또는 이의 엑소좀풍부배양액을 유효성분으로 포함하는 염증성 질환의 예방 또는 치료용 조성물
KR102456805B1 (ko) * 2020-12-02 2022-10-24 충북대학교 산학협력단 불멸화 개줄기세포 또는 이의 엑소좀풍부배양액을 유효성분으로 포함하는 염증성 질환의 예방 또는 치료용 조성물
CN112941033A (zh) * 2021-03-11 2021-06-11 深圳市人民医院 永生化饲养层细胞株的构建方法、永生化饲养层细胞株及应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5686306A (en) * 1992-05-13 1997-11-11 Board Of Regents, The University Of Texas System Methods and reagents for lengthening telomeres
US5919997A (en) * 1993-11-18 1999-07-06 Cold Spring Habor Labortary Transgenic mice having modified cell-cycle regulation
US5729597A (en) * 1995-05-16 1998-03-17 At&T Corp Service and information management system for a telecommunications network
US5629159A (en) * 1995-06-07 1997-05-13 California Institute Of Technology Immortalization and disimmortalization of cells
US6013516A (en) * 1995-10-06 2000-01-11 The Salk Institute For Biological Studies Vector and method of use for nucleic acid delivery to non-dividing cells
ES2319238T3 (es) * 1996-07-01 2009-05-05 Gemin X Pharmaceuticals Canada Inc. Composiciones para modular la longitud de los talomeros.
CA2265522A1 (en) * 1996-09-17 1998-03-26 The Salk Institute For Biological Studies Retroviral vectors capable of transducing non-dividing cells
JP2001513643A (ja) * 1997-03-06 2001-09-04 ウーベルラ、クラウス レンチウイルスをベースとするベクター及びベクター系
ATE298371T1 (de) * 1997-09-24 2005-07-15 Univ California Nicht-primaten lentivirale vektoren und verpackungssysteme
AU759437B2 (en) * 1998-01-12 2003-04-17 Cold Spring Harbor Laboratory Extension of cellular lifespan, methods and reagents
ES2291025T3 (es) * 1998-05-13 2008-02-16 Genetix Pharmaceuticals Inc. Celulas lentivirales de empaquetamiento.

Similar Documents

Publication Publication Date Title
Korber et al. T-cell vaccine strategies for human immunodeficiency virus, the virus with a thousand faces
Salminen et al. Identification of breakpoints in intergenotypic recombinants of HIV type 1 by bootscanning
Courgnaud et al. Characterization of a novel simian immunodeficiency virus with a vpu gene from greater spot-nosed monkeys (Cercopithecus nictitans) provides new insights into simian/human immunodeficiency virus phylogeny
Masemola et al. Hierarchical targeting of subtype C human immunodeficiency virus type 1 proteins by CD8+ T cells: correlation with viral load
Louwagie et al. Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin
Gao et al. A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1
Courgnaud et al. Characterization of a novel simian immunodeficiency virus from guereza colobus monkeys (Colobus guereza) in Cameroon: a new lineage in the nonhuman primate lentivirus family
Yang et al. Stoichiometry of antibody neutralization of human immunodeficiency virus type 1
DK33190A (da) Hiv-3 retrovirus og anvendelse heraf
JP2019504868A5 (enExample)
GB2331522A (en) Lentiviral vectors
Santra et al. Recombinant poxvirus boosting of DNA-primed rhesus monkeys augments peak but not memory T lymphocyte responses
Barlow et al. Characterization of a novel simian immunodeficiency virus (SIVmonNG1) genome sequence from a mona monkey (Cercopithecus mona)
De Boer et al. How germinal centers evolve broadly neutralizing antibodies: the breadth of the follicular helper T cell response
JP2006523224A5 (enExample)
Rubens et al. HIV vaccine: recent advances, current roadblocks, and future directions
Hel et al. Impairment of Gag-specific CD8+ T-cell function in mucosal and systemic compartments of simian immunodeficiency virus mac251-and simian-human immunodeficiency virus KU2-infected macaques
Johnson et al. Molecular clones of SIVsm and SIVagm: experimental infection of macaques and African green monkeys
Duerr et al. V2-specific antibodies in HIV-1 vaccine research and natural infection: controllers or surrogate markers
DE60019125D1 (de) Konditionell kontrollierter, attenuierter hiv-1 impfstoff
ATE323776T1 (de) Retrovirale vektoren zur expression in embryonalen zellen
Shibata et al. Mutational analysis of simian immunodeficiency virus from African green monkeys and human immunodeficiency virus type 2
Blancou et al. Simian immunodeficiency virus promoter exchange results in a highly attenuated strain that protects against uncloned challenge virus
WO2003029285A3 (en) Identification of cd8 epitopes from hiv-1 proteins for prevention and therapy of hiv infections
Sonigo et al. Design and trials of AIDS vaccines